Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00285415 · ClinicalTrials.gov registry record · Phase 2
A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation
A Phase 2 study, sponsored by Carilion Clinic.
- Terminated
- Registry status
- Phase 2
- Development phase
- 46
- Enrollment target
NCT00285415 is a Phase 2 study that was terminated before completion, run by Carilion Clinic. The registered enrollment target is 46 participants.
The verdict
NCT00285415, a Phase 2 study, was terminated before completion, sponsored by Carilion Clinic.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of the combination of the two drugs, docetaxel (Taxotere®) and carboplatin (Paraplatin®) followed by radiation directed at the tumor in treating your endometrial cancer.
Interventions
- DRUG Docetaxel and Carboplatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2005-04 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00285415
The ClinicalTrials.gov registry entry for NCT00285415 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carilion Clinic, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Docetaxel and Carboplatin is the first listed.
NCT00285415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00285415 about?
NCT00285415 is a clinical study titled "A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation". The purpose of this study is to determine the effectiveness of the combination of the two drugs, docetaxel (Taxotere®) and carboplatin (Paraplatin®) followed by radiation directed at the tumor in treating your endometrial cancer.
What is the current status of trial NCT00285415?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2005-04. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00285415?
The interventions under investigation include: Docetaxel and Carboplatin (DRUG).
Who is sponsoring clinical trial NCT00285415?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.